Back to Georgia

HB334 • 2025

Sickle Cell Disease Protection Act; enact

Sickle Cell Disease Protection Act; enact

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Crawford, Omari
Last action
2026-05-05
Official status
House Date Signed by Governor
Effective date
Not listed

Plain English Breakdown

The specific details regarding how public input is gathered and used are mentioned but not defined in the available text.

Annual Review of Sickle Cell Disease Care for Medicaid Recipients

This law requires Georgia's Department of Community Health to review medications and treatments for sickle cell disease among Medicaid recipients, gather public input, and publish an annual report.

What This Bill Does

  • Requires the Department of Community Health to conduct an annual review of medications and treatment options for sickle cell disease specifically for Medicaid recipients.
  • Provides a process for members of the public to give input during this review.
  • Orders the department to publish an annual report based on its findings.

Who It Names or Affects

  • The Georgia Department of Community Health
  • Medicaid recipients with sickle cell disease

Limits and Unknowns

  • The official summary does not specify which medications or treatments will be included in the review.
  • It is unclear how public input will be collected or used to change care standards based on this text alone.
  • The law does not detail penalties if the department fails to submit the annual report.

Bill History

  1. 2026-05-05 Georgia General Assembly

    House Date Signed by Governor

Official Summary Text

Sickle Cell Disease Protection Act; enact